AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-87
Results: 1-25/87
PILOT-STUDY OF SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-12 IN METASTATIC MELANOMA
Authors: BAJETTA E DELVECCHIO M MORTARINI R NADEAU R RAKHIT A RIMASSA L FOWST C BORRI A ANICHINI A PARMIANI G
Citation: E. Bajetta et al., PILOT-STUDY OF SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-12 IN METASTATIC MELANOMA, Clinical cancer research, 4(1), 1998, pp. 75-85
PILOT-STUDY OF SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-12 IN METASTATIC MELANOMA
Authors: BAJETTA E DELVECCHIO M MORTARINI R NADEAU R RAKHIT A RIMASSA L FOWST C BORRI A ANICHINI A PARMIANI G
Citation: E. Bajetta et al., PILOT-STUDY OF SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-12 IN METASTATIC MELANOMA, Clinical cancer research, 4(1), 1998, pp. 75-85
EFFECTS OF SHORT-TERM PREOPERATIVE TAMOXIFEN ON STEROID-RECEPTOR AND KI-67 EXPRESSION IN PRIMARY BREAST-CANCER - AN IMMUNOCYTOCHEMICAL STUDY
Authors: BAJETTA E CELIO L DILEO A BARTOLI C PILOTTI S LEUTNER M BONO A FERRARI L BUZZONI R ZILEMBO N DECANDIS D MOGLIA D
Citation: E. Bajetta et al., EFFECTS OF SHORT-TERM PREOPERATIVE TAMOXIFEN ON STEROID-RECEPTOR AND KI-67 EXPRESSION IN PRIMARY BREAST-CANCER - AN IMMUNOCYTOCHEMICAL STUDY, International journal of oncology, 12(4), 1998, pp. 853-858
BONE METABOLISM MARKERS IN PREMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH THE LHRH ANALOG TRIPTORELIN ALONE OR IN COMBINATION WITH THE AROMATASE INHIBITOR FORMESTANE
Authors: MARTINETTI A CELIO L FERRARI L ZILEMBO N MARIANI L SEREGNI E BOMBARDIERI E GALANTE E STANI S BAJETTA E
Citation: A. Martinetti et al., BONE METABOLISM MARKERS IN PREMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH THE LHRH ANALOG TRIPTORELIN ALONE OR IN COMBINATION WITH THE AROMATASE INHIBITOR FORMESTANE, Annals of oncology, 9, 1998, pp. 87-87
THE COMBINATION OF AN LH-RH ANALOG AND AN AROMATASE INHIBITOR (AL) INPREMENOPAUSAL BREAST-CANCER - INFLUENCE ON THE INSULIN-LIKE-GROWTH-FACTOR (IGF) SYSTEM AND THE INTERLEUKIN (IL)-6
Authors: FERRARI L MARTINETTI A CELIO L BUZZONI R MARIANI L SEREGNI E BOMBARDIERI E POZZI P PROCOPIO G BAJETTA E
Citation: L. Ferrari et al., THE COMBINATION OF AN LH-RH ANALOG AND AN AROMATASE INHIBITOR (AL) INPREMENOPAUSAL BREAST-CANCER - INFLUENCE ON THE INSULIN-LIKE-GROWTH-FACTOR (IGF) SYSTEM AND THE INTERLEUKIN (IL)-6, Annals of oncology, 9, 1998, pp. 126-126
ORAL DOXIFLURIDINE (5-DFUR) AND RADIATION-THERAPY FOR UNRESECTABLE LOCALLY ADVANCED PANCREATIC-CANCER - A PHASE-II STUDY OF ITALIAN TRIALS IN MEDICAL ONCOLOGY (ITMO) GROUP
Authors: BAJETTA E DIBARTOLOMEO M ARTALE S STANI S RICCI SB CASSATA A MAZZAFERRO V BOZZETTI F
Citation: E. Bajetta et al., ORAL DOXIFLURIDINE (5-DFUR) AND RADIATION-THERAPY FOR UNRESECTABLE LOCALLY ADVANCED PANCREATIC-CANCER - A PHASE-II STUDY OF ITALIAN TRIALS IN MEDICAL ONCOLOGY (ITMO) GROUP, Annals of oncology, 9, 1998, pp. 240-240
PHASE-II STUDY OF GEMCITABINE (GEM) PLUS NAVELBINE (NVB) IN PREVIOUSLY UNTREATED STAGE-III OR IV NONSMALL CELL LUNG-CANCER (NSCLC)
Authors: DECANDIS D BIDOLI P CRESTA S ARTALE S MASI G BAJETTA E
Citation: D. Decandis et al., PHASE-II STUDY OF GEMCITABINE (GEM) PLUS NAVELBINE (NVB) IN PREVIOUSLY UNTREATED STAGE-III OR IV NONSMALL CELL LUNG-CANCER (NSCLC), Annals of oncology, 9, 1998, pp. 460-460
STEROIDAL AROMATASE INHIBITOR IN ELDERLY PATIENTS
Authors: BAJETTA E ZILEMBO N POZZI P LATORRE I BICHISAO E
Citation: E. Bajetta et al., STEROIDAL AROMATASE INHIBITOR IN ELDERLY PATIENTS, Annals of oncology, 9, 1998, pp. 7-7
PRELIMINARY EXPERIENCE WITH HIGH-DOSE CISPLATIN, REDUCED GLUTATHIONE AND NATURAL INTERFERON-ALPHA IN DACARBAZINE-RESISTANT MALIGNANT-MELANOMA
Authors: BAJETTA E RIMASSA L CARNAGHI C DELVECCHIO M CELIO L CASSATA A
Citation: E. Bajetta et al., PRELIMINARY EXPERIENCE WITH HIGH-DOSE CISPLATIN, REDUCED GLUTATHIONE AND NATURAL INTERFERON-ALPHA IN DACARBAZINE-RESISTANT MALIGNANT-MELANOMA, Tumori, 84(1), 1998, pp. 48-51
RANDOMIZED TRIAL OF IRINOTECAN VERSUS FLUOROURACIL BY CONTINUOUS-INFUSION AFTER FLUOROURACIL FAILURE IN PATIENTS WITH METASTATIC COLORECTAL-CANCER
Authors: ROUGIER P VANCUTSEM E BAJETTA E NIEDERLE N POSSINGER K LABIANCA R NAVARRO M MORANT R BLEIBERG H WILS J AWAD L HERAIT P JACQUES C
Citation: P. Rougier et al., RANDOMIZED TRIAL OF IRINOTECAN VERSUS FLUOROURACIL BY CONTINUOUS-INFUSION AFTER FLUOROURACIL FAILURE IN PATIENTS WITH METASTATIC COLORECTAL-CANCER, Lancet, 352(9138), 1998, pp. 1407-1412
ORAL DOXIFLURIDINE PLUS LEVOLEUCOVORIN IN ELDERLY PATIENTS WITH ADVANCED BREAST-CANCER
Authors: BAJETTA E BIGANZOLI L CARNAGHI C DIBARTOLOMEO M SPAGNOLI I CASSATA A GALANTE E MARIANI L STAMPINO CG BUZZONI R
Citation: E. Bajetta et al., ORAL DOXIFLURIDINE PLUS LEVOLEUCOVORIN IN ELDERLY PATIENTS WITH ADVANCED BREAST-CANCER, Cancer, 83(6), 1998, pp. 1136-1141
5-FLUOROURACIL, DACARBAZINE, AND EPIRUBICIN IN THE TREATMENT OF PATIENTS WITH NEUROENDOCRINE TUMORS
Authors: BAJETTA E RIMASSA L CARNAGHI C SEREGNI E FERRARI L DIBARTOLOMEO M REGALIA E CASSATA A PROCOPIO G MARIANI L
Citation: E. Bajetta et al., 5-FLUOROURACIL, DACARBAZINE, AND EPIRUBICIN IN THE TREATMENT OF PATIENTS WITH NEUROENDOCRINE TUMORS, Cancer, 83(2), 1998, pp. 372-378
FEP REGIMEN (EPIDOXORUBICIN, ETOPOSIDE AND CISPLATIN) IN ADVANCED GASTRIC-CANCER, WITH OR WITHOUT LOW-DOSE GM-CSF - AN ITALIAN TRIAL IN MEDICAL ONCOLOGY (ITMO) STUDY
Authors: BAJETTA E DIBARTOLOMEO M CARNAGHI C BUZZONI R MARIANI L GEBBIA V COMELLA G PINOTTI G IANNIELLO G SCHIEPPATI G BOCHICCHIO AM MAIORINO L
Citation: E. Bajetta et al., FEP REGIMEN (EPIDOXORUBICIN, ETOPOSIDE AND CISPLATIN) IN ADVANCED GASTRIC-CANCER, WITH OR WITHOUT LOW-DOSE GM-CSF - AN ITALIAN TRIAL IN MEDICAL ONCOLOGY (ITMO) STUDY, British Journal of Cancer, 77(7), 1998, pp. 1149-1154
EFFECTS OF AROMATASE COMPLEX SELECTIVE-INHIBITION ON INSULIN-LIKE-GROWTH-FACTOR-1 AND INSULIN-LIKE-GROWTH-FACTOR BINDING-PROTEIN-3 CIRCULATING LEVELS IN BREAST-CANCER
Authors: FERRARI L BAJETTA E SEREGNI E MARTINETTI A ZILEMBO N NOBERASCO C BUZZONI R BOTTI C MASSARON S BICHISAO E CELIO L BOMBARDIERI E
Citation: L. Ferrari et al., EFFECTS OF AROMATASE COMPLEX SELECTIVE-INHIBITION ON INSULIN-LIKE-GROWTH-FACTOR-1 AND INSULIN-LIKE-GROWTH-FACTOR BINDING-PROTEIN-3 CIRCULATING LEVELS IN BREAST-CANCER, International journal of oncology, 11(1), 1997, pp. 163-167
SERUM MARKERS OF BONE METASTASES IN POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH FORMESTANE
Authors: MARTINETTI A BAJETTA E SEREGNI E ZILEMBO N FERRARI L NOBERASCO C MASSARON S RIMASSA L BOMBARDIERI E
Citation: A. Martinetti et al., SERUM MARKERS OF BONE METASTASES IN POSTMENOPAUSAL BREAST-CANCER PATIENTS TREATED WITH FORMESTANE, Tumor biology, 18(4), 1997, pp. 197-205
THE AROMATASE INHIBITOR LETROZOLE IN ADVANCED BREAST-CANCER - EFFECTSON SERUM-INSULIN LIKE GROWTH-FACTOR (IGF)-I AND IGF BINDING PROTEIN-3LEVELS
Authors: BAJETTA E FERRARI L CELIO L MARIANI L MICELI R DILEO A ZILEMBO N BUZZONI R SPAGNOLI I MARTINETTI A BICHISAO E SEREGNI E
Citation: E. Bajetta et al., THE AROMATASE INHIBITOR LETROZOLE IN ADVANCED BREAST-CANCER - EFFECTSON SERUM-INSULIN LIKE GROWTH-FACTOR (IGF)-I AND IGF BINDING PROTEIN-3LEVELS, Journal of steroid biochemistry and molecular biology, 63(4-6), 1997, pp. 261-267
THE LHRH ANALOG TRIPTORELINE (TRP) WITH OR WITHOUT THE AROMATASE INHIBITOR FORMESTANE (4-OHA) IN PREMENOPAUSAL ADVANCED BREAST-CANCER - A STUDY BY THE ITMO GROUP
Authors: CELIO L MARTINETTI A FERRARI L BUZZONI R BOMBARDIERI E ZILEMBO N MAIORINO L BAJETTA E
Citation: L. Celio et al., THE LHRH ANALOG TRIPTORELINE (TRP) WITH OR WITHOUT THE AROMATASE INHIBITOR FORMESTANE (4-OHA) IN PREMENOPAUSAL ADVANCED BREAST-CANCER - A STUDY BY THE ITMO GROUP, European journal of cancer, 33, 1997, pp. 691-691
THE MINIMAL EFFECTIVE EXEMESTANE DOSE FOR ENDOCRINE ACTIVITY IN ADVANCED BREAST-CANCER
Authors: BAJETTA E ZILEMBO N NOBERASCO C MARTINETTI A MARIANI L FERRARI L BUZZONI R GRECO M BARTOLI C SPAGNOLI I DANESINI GM ARTALE S PAOLINI J
Citation: E. Bajetta et al., THE MINIMAL EFFECTIVE EXEMESTANE DOSE FOR ENDOCRINE ACTIVITY IN ADVANCED BREAST-CANCER, European journal of cancer, 33(4), 1997, pp. 587-591
DOXIFLURIDINE IN COLORECTAL-CANCER PATIENTS RESISTANT TO 5-FLUOROURACIL (5-FU) CONTAINING REGIMENS
Authors: BAJETTA E DIBARTOLOMEO M SOMMA L DELVECCHIO M ARTALE S ZUNINO F BIGNAMI P MAGNANI E BUZZONI R
Citation: E. Bajetta et al., DOXIFLURIDINE IN COLORECTAL-CANCER PATIENTS RESISTANT TO 5-FLUOROURACIL (5-FU) CONTAINING REGIMENS, European journal of cancer, 33(4), 1997, pp. 687-690
A MULTICENTER, RANDOMIZED, PHARMACOKINETIC, ENDOCRINE AND CLINICAL-STUDY TO EVALUATE FORMESTANE IN BREAST-CANCER PATIENTS AT FIRST RELAPSE - ENDOCRINE AND CLINICAL-RESULTS
Authors: BAJETTA E ZILEMBO N BARNI S NOBERASCO C MARTINETTI A FERRARI L SCHIEPATTI G BUZZONI R JIRILLO A AMICHETTI M DAPRILE M COMELLA G BICHISAO E BOLELLI GF ATTILI A BOMBARDIERI E
Citation: E. Bajetta et al., A MULTICENTER, RANDOMIZED, PHARMACOKINETIC, ENDOCRINE AND CLINICAL-STUDY TO EVALUATE FORMESTANE IN BREAST-CANCER PATIENTS AT FIRST RELAPSE - ENDOCRINE AND CLINICAL-RESULTS, Annals of oncology, 8(7), 1997, pp. 649-654
QUALITY-OF-LIFE ASSESSMENT AND CLINICAL DECISION-MAKING
Authors: CASALI P LICITRA L COSTANTINI M SANTORO A VITERBORI P BAJETTA E BRUZZI P
Citation: P. Casali et al., QUALITY-OF-LIFE ASSESSMENT AND CLINICAL DECISION-MAKING, Annals of oncology, 8(12), 1997, pp. 1207-1211
VINORELBINE, CISPLATIN, AND 5-FLUOROURACIL AS INITIAL TREATMENT FOR PREVIOUSLY UNTREATED, UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - RESULTS OF A PHASE-II MULTICENTER STUDY
Authors: GEBBIA V MANTOVANI G FARRIS A AGOSTARA B DESOGUS A CURRELI L MOSCHELLA F DIGREGORIO C BAJETTA E GEBBIA N
Citation: V. Gebbia et al., VINORELBINE, CISPLATIN, AND 5-FLUOROURACIL AS INITIAL TREATMENT FOR PREVIOUSLY UNTREATED, UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - RESULTS OF A PHASE-II MULTICENTER STUDY, Cancer, 79(7), 1997, pp. 1394-1400
RANDOMIZED PHASE-II EVALUATION OF FLUDARABINE (RDA) AND 2-CHLOREDEOSSIADENOSINE (CDA) IN THE TREATMENT OF RELAPSED REFRACTORY LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL) AND CLL/
Authors: TONDINI C BALZAROTTI M RAMPINELLI I LUONI M DEPAOLI A VALAGUSSA P SANTORO A BAJETTA E BONADONNA G BREGNI M
Citation: C. Tondini et al., RANDOMIZED PHASE-II EVALUATION OF FLUDARABINE (RDA) AND 2-CHLOREDEOSSIADENOSINE (CDA) IN THE TREATMENT OF RELAPSED REFRACTORY LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL) AND CLL/, Blood, 90(10), 1997, pp. 1532-1532
PHASE-II STUDY OF VINORELBINE IN PATIENTS WITH PRETREATED ADVANCED OVARIAN-CANCER - ACTIVITY IN PLATINUM-RESISTANT DISEASE
Authors: BAJETTA E DILEO A BIGANZOLI L MARIANI L CAPPUZZO F DIBARTOLOMEO M ZILEMBO N ARTALE S MAGNANI E CELIO L BUZZONI R CARNAGHI C
Citation: E. Bajetta et al., PHASE-II STUDY OF VINORELBINE IN PATIENTS WITH PRETREATED ADVANCED OVARIAN-CANCER - ACTIVITY IN PLATINUM-RESISTANT DISEASE, Journal of clinical oncology, 14(9), 1996, pp. 2546-2551
PRELIMINARY EXPERIENCE WITH RHU IL-12 IN THE TREATMENT OF METASTATIC MELANOMA
Authors: DELVECCHIO M MORTARINI R RIMASSA L FOWST C ANICHINI A PARMIANI G CASCINELLI N BAJETTA E
Citation: M. Delvecchio et al., PRELIMINARY EXPERIENCE WITH RHU IL-12 IN THE TREATMENT OF METASTATIC MELANOMA, Journal of clinical oncology, 14(5), 1996, pp. 2011-2011
Risultati: 1-25 | 26-50 | 51-75 | 76-87